← FDA DRUG APPROVALS

FDA NDA · NDA016144

ETHAMIDE

Sponsor: ALLERGAN

APPLICATION
NDA016144
TYPE
NDA
ORIGINAL APPROVAL
1966-10-12
LATEST ACTION
1996-08-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ETHAMIDEDiscontinued
ETHOXZOLAMIDE 125MG · TABLET · ORAL

Approval history

1996-08-05Labeling · Supplement 7AP
1978-10-13Labeling · Supplement 11AP
1978-10-12Labeling · Supplement 9AP
1978-10-12Labeling · Supplement 10AP
1974-12-09Labeling · Supplement 8AP
1966-10-12Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →